• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Personalis, Inc. - Common Stock (NQ:PSNL)

6.340 -0.980 (-13.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Personalis, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection
April 22, 2025
From Personalis, Inc.
Via Business Wire
News headline image
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It. ↗
April 17, 2025
A revolution in oncology could help cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences. 
Via Investor's Business Daily
News headline image
What 5 Analyst Ratings Have To Say About Personalis ↗
April 10, 2025
 
Via Benzinga
News headline image
Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference
March 26, 2025
From Personalis, Inc.
Via Business Wire
News headline image
A Glimpse Into The Expert Outlook On Personalis Through 7 Analysts ↗
February 28, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2025 ↗
February 27, 2025
 
Via Benzinga
News headline image
Personalis Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) ↗
January 27, 2025
 
Via Benzinga
News headline image
This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
March 17, 2025
 
Via Benzinga
News headline image
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip ↗
March 08, 2025
Ark Invest made significant trades on Friday, selling shares of RBLX, ROKU, PATH and buying shares of IBTA, PSNL, ABSI, and RXRX. 
Via Benzinga
News headline image
New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection
March 03, 2025
From Personalis, Inc.
Via Business Wire
News headline image
Key Takeaways From Personalis Analyst Ratings ↗
November 07, 2024
 
Via Benzinga
News headline image
What Analysts Are Saying About Personalis Stock ↗
November 07, 2024
 
Via Benzinga
News headline image
Personalis Reports Fourth Quarter and Full Year 2024 Financial Results
February 27, 2025
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference
February 18, 2025
From Personalis, Inc.
Via Business Wire
News headline image
Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday ↗
February 14, 2025
 
Via Benzinga
News headline image
Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results
February 13, 2025
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 28, 2025
From Personalis, Inc.
Via Business Wire
News headline image
New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer
January 13, 2025
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue
January 07, 2025
From Personalis, Inc.
Via Business Wire
News headline image
Dow Surges Over 600 Points, Gold Jumps 1.5% ↗
December 20, 2024
 
Via Benzinga
Topics Stocks
News headline image
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses
December 20, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NASDAQ:PSNL),(NASDAQ:TEM),(NASDAQ:CKPT) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher ↗
December 20, 2024
 
Via Benzinga
News headline image
Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Friday ↗
December 20, 2024
 
Via Benzinga
News headline image
Stock Of The Day: Where Does The Merck Downtrend End? ↗
December 19, 2024
Shares of Merck & Co (MRK) continue to trend lower. If they reach the $95.00 level, there is a good chance they find support and reverse. 
Via Benzinga
News headline image
Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna
December 19, 2024
From Personalis, Inc.
Via Business Wire
News headline image
Personalis and Tempus Expand Collaboration to Biopharma
December 16, 2024
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Participate at Upcoming Investor Conferences
November 20, 2024
From Personalis, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
November 07, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
November 07, 2024
 
Via Benzinga
News headline image
Personalis Reports Third Quarter 2024 Financial Results
November 06, 2024
From Personalis, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap